Allarity Therapeutics, Inc. - COM (ALLR)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COM
Total 13F shares
195,090
Share change
+102,729
Total reported value
$197,041
Price per share
$1.01
Number of holders
10
Value change
+$108,103
Number of buys
7
Number of sells
4

Institutional Holders of Allarity Therapeutics, Inc. - COM (ALLR) as of Q2 2025

As of 30 Jun 2025, Allarity Therapeutics, Inc. - COM (ALLR) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 195,090 shares. The largest 10 holders included XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, JANE STREET GROUP, LLC, Squarepoint Ops LLC, Tower Research Capital LLC (TRC), CITIGROUP INC, BANK OF AMERICA CORP /DE/, OSAIC HOLDINGS, INC., and DANSKE BANK A/S. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.